Description
This project is being undertaken through the University of Southern Queensland. The purpose of this study is to understand people's experiences of using psychedelic substances. Increasingly, psychedelics are being used in a therapeutic context to treat a range of mental health concerns. We are interested in your perspectives on what might make psychedelic therapy more safe and inclusive, based on your own experience using a psychedelic substance. Findings from this study will help to inform the ongoing development and refinement of psychedelic psychotherapy protocols.
We are recruiting anyone who is over 18 and has had at least one experience using a ‘classic’ psychedelic compound. That could include psilocybin (i.e., magic mushrooms), LSD (i.e., acid), DMT (either as Ayahuasca or inhaled DMT), or mescaline (i.e., cactus juice).
Participation
Your participation will involve completion of an online questionnaire that will take approximately 30 minutes of your time.
Questions will broadly explore your experiences using a classic psychedelic compound and also your perspectives on what you think might make psychedelic assisted psychotherapy more safe and inclusive. Some questions include, 1) what helped you to process / understand the experiences that arose during your psychedelic trip, and 2) describe what aspects of your psychedelic experience you found helpful or therapeutic. Feel free to provide as much or as little detail as you like or skip questions completely if you do not feel comfortable responding. There are no correct answers to the questions we will ask. You will be able to flow back and forth between questions as required to add or edit responses. All data collected is anonymous.
Your participation in this project is entirely voluntary. If you do not wish to take part, you are not obliged to. If you decide to take part and later change your mind, you are free to withdraw from the project at any stage. You will be unable to withdraw data collected about yourself after you have participated in the questionnaire due to the anonymous nature of the data. Your decision whether you take part, do not take part, or take part and then withdraw, will in no way impact your current or future relationship with the University of Southern Queensland or The University of Queensland.
Expected benefits
It is expected that this project will not directly benefit you. However, it may benefit others in the future by helping shape the way psychedelic therapy is designed to be more safe and inclusive for everyone.
Risks
During this survey you will not be asked to disclose any illegal activity, however this may inadvertently arise during participation. We are undertaking a variety of steps to protect your privacy and to not incriminate you in the event of disclosure of illegal activity. Firstly, data collected is anonymous and non-identifiable. In the potential instance that open-ended text provides data that may reveal your identity, we will redact responses to protect your privacy. Secondly, your data will be stored securely and anonymously. As well, the survey tool used to collect your information will not collect your IP address. By consenting to this research, you acknowledge this risk, and the intentional steps we are taking to protect your identity.
Outside of this, participating in the questionnaire will pose no risk beyond normal day-to-day living. Sometimes thinking about the sorts of issues raised in the questionnaire can create some uncomfortable or distressing feelings. If you need to talk to someone about this immediately, please contact your support networks, or access a service such as Lifeline: 131114 or Qlife: 1800184527. Attached to this document is a list of support services from around the globe that may be useful in helping you find a suitable service.
Privacy and Confidentiality
All comments and responses are confidential unless required by law. The names of individual persons are not required in any of the responses. Data may be used for future research purposes, however due to the anonymous nature of data collection, all responses are non-identifiable. Participants may contact the Principal Investigator Grace Wang for a 1–2-page summary of the project results in December 2024.
Any data collected as a part of this project will be stored securely, as per University of Southern Queensland’s Research Data and Primary Materials Management Procedure. Data collected will be non-identifiable and accessible only by members of the research team above which includes external researchers from UQ.
Consent to participate
Clicking on the ‘Submit’ button at the conclusion of the questionnaire is accepted as an indication of your consent to participate in this project.
Questions
Please refer to the Research team contact details at the bottom of the form to have any questions answered or to request further information about this project.
Concerns or complaints
If you have any concerns or complaints about the ethical conduct of the project, you may contact the University of Southern Queensland, Manager of Research Integrity and Ethics on +61 7 4631 1839 or email researchintegrity@usq.edu.au. The Manager of Research Integrity and Ethics is not connected with the research project and can address your concern in an unbiased manner.
Research team contact details
Principal Investigator:
A/Professor Grace Wang
Email: grace.wang@usq.edu.au
Telephone: +61 7 4631 1340
Supervisor / Co-investigator(s):
Professor Amy Mullens
Email: amy.mullens@usq.edu.au
Dr Renee Ireland
Email: renee.ireland@usq.edu.au
Dr Riccardo Miceli McMillan
Email: r.micelimcmillan@uq.edu.au
Mr James Fowler
Email: james.fowler@uq.edu.au
Dr Samantha Brown
Email: samantha.brown@usq.edu.au
A/Professor Annette Bromdal
Email: annette.bromdal@usq.edu.au
Support resources
Below is a list of services from different places around the world that you might like to contact if you experience any distress during this study.
Country
|
Name of Service
|
Contact number / website
|
America
|
Mental Health America
|
https://www.mhanational.org/get-involved/contact-us
|
America
|
National Suicide Hotline
|
1-800-273-8255
|
America
|
The Trevor Project
|
1-866-488-7386
|
Australia
|
Q/Life
|
1800 184 527 / qlife.org.au
|
Australia
|
Lifeline
|
13 11 14
|
Belgium
|
Stichting Zelfmoordlijn 1813 (Dutch)
|
1813
|
Belgium
|
Stichting Centre de Prévention du Suicide (French)
|
080032123
|
Brazil
|
Centro de Valorização da Vida
|
188 / http://www.cvv.org.br/
|
Canada
|
Canada Suicide Prevention Service
|
1-833-456-4566
|
Canada
|
Crisis Text Line
|
Via texting ‘HOME’ or ‘PARLER’ to 686868
|
Canada
|
LGBTQ Youth Line
|
1-800-268-9688
|
China
|
Lifeline China
|
400 821 1215
|
Denmark
|
Livslinien
|
70 201 201
|
France
|
Suicide Ecoute
|
0033 145 39 4000
|
Germany
|
Telefonseelsorge Deutschland (National)
|
German speaking: 0800-111 0 222
English speaking: 03-44 01 06 07
|
Italy
|
Samaritans – ONLUS
|
800 86 00 22
|
Italy
|
Telefono Amico
|
199284284
|
Japan
|
TELL
|
http://telljp.com/lifeline/
|
Kenya
|
Befrienders Kenya
|
+254 722 178 177
|
Mexico
|
SAPTEL
|
(55) 5259-8121
|
New Zealand
|
0800 OUTLINE
|
0800 688 5463
|
Poland
|
Olsztynski Telefon Zaufania 'Anonimowy Przyjaciel
|
89 19288
|
Russia
|
Suicide Helpline
|
(495) 625 3101
|
South Africa
|
The Triangle Project
|
(021) 712 6699
|
South Korea
|
Lifeline Korea
|
1588-9191
|
Spain
|
Teléfono de la Esperanza
|
717003717
|
Sri Lanka
|
Sri Lanka Sumithrayo – Bandarawela
|
011 057 2222662
|
Sudan
|
Befrienders Khartoum
|
(249) 11-555-253
|
Sweden
|
Självmordslinjen (Suicide prevention hotline)
|
90101
|
Taiwan
|
Lifeline Taiwan
|
1995
|
United Arab Emirates
|
National Committee for the Promotion of Mental Health
|
920033360
|
United Kingdom
|
SANEline
|
0300 304 7000
|
United Kingdom
|
Switchboard
|
0300 330 0630
|
This list is only a small number of resources available to you. Please see some of the following links if you require support and your country is not currently listed and or you don’t feel comfortable contacting the organizations listed:
https://en.wikipedia.org/wiki/List_of_suicide_crisis_lines
https://checkpointorg.com/global/
|
Welcome to our survey exploring your experience with psychedelics compounds!
In this survey, we are interested in understanding your experience with psychedelic compounds (e.g., magic mushrooms/psilocybin, Ayahuasca, LSD, DMT). Given the rise in the use of psychedelic substances as a part of therapy, we are particularly interested in hearing your perspectives on how to make psychedelic assisted psychotherapy more inclusive and safe for everyone.
Please answer every question honestly and remember that all responses are completely anonymous.
Please press the 'next' button to provide your informed consent and complete the survey.
There are 21 questions in this survey.